Introduction
============

Cytochrome P450 (CYP) enzymes catalyze the oxidation of exogenous and endogenous substrates, such as drugs, environmental chemicals, plant metabolites, fatty acids, and steroids. The enzymes are membrane-binding heme proteins, and they are widely expressed in prokaryotes and eukaryotes ([@evv056-B35]). All the eukaryotic CYPs are considered to have been derived from a single common ancestor ([@evv056-B33], although an ancestral enzyme has not yet been determined ([@evv056-B37]; [@evv056-B49]). A large variety of CYP proteins are necessary to interact with a large number of substrates, and the variety of substrates is considered to reflect the species-specificity for the habitat, environment, and diet ([@evv056-B10]). In humans, *Homo sapiens*, the *CYP* gene family consists of 57 functional genes and 58 pseudogenes, whereas in mice, *Mus musculus*, there are 102 functional genes and 88 pseudogenes ([@evv056-B36]). The putative number of *CYP* genes varies between organisms as shown in the Cytochrome P450 Homepage ([@evv056-B34]), including the Pacific transparent sea squirt, *Ciona savignyi*, and rice, *Oryza sativa*, with 97 and 323 functional genes, respectively, and as low as three expressed *CYP* genes in the budding yeast, *Saccharomyces cerevisiae*. Their genes are all members of the *CYP* superfamily and can be classified into two groups, with respect to their pattern of evolution ([@evv056-B57]; [@evv056-B12]; [@evv056-B23]). Products of the first group primarily function in metabolizing the endogenous substrates, and those genes undergo few gene duplications over long periods of time. On the other hand, products of the second group mainly metabolize exogenous substrates, and those genes have undergone frequent gene duplications or gene loss (birth-and-death evolution).

The hominin *CYP2D* subfamily, a member of the second group, consists of a functional C*YP2D6* and two paralogs, C*YP2D7* and C*YP2D8* ([@evv056-B34]), and the latter two genes often are not functional in some species ([@evv056-B68]). The human CYP2D6 enzyme has a high affinity for alkaloids, and it detoxifies alkaloids ([@evv056-B5]). The enzyme is also important for metabolizing about 25% of commonly used drugs, such as antidepressants, β-blockers, and antiarrhythmics ([@evv056-B21]). The three human *CYP2D* genes are located within a contiguous region of about 45 kb on chromosome 22 ([@evv056-B25]). The nucleotide sequences of the two pseudogenes (*CYP2D7P* and *CYP2D8P*) are similar to that of *CYP2D6*. The *CYP2D7P* gene has a single frameshift mutation in the first exon, which causes a premature stop codon downstream. Alternative mRNAs from this pseudogene have been identified in human breast ([@evv056-B19], lung ([@evv056-B19], and brain ([@evv056-B40]; [@evv056-B9]). Of them, a functional transcript was observed in some individuals in an Indian population ([@evv056-B40]). On the other hand, there is no observation of mRNA from *CYP2D8P* gene.

We previously identified the gene organization of the *CYP2D* subfamily in nonhuman primates, including the chimpanzee, *Pan troglodytes*, Sumatran orangutan, *Pongo pygmaeus abelii*, rhesus monkey, *Macaca mulatta*, and white-tufted-ear marmoset, *Callithrix jacchus* ([@evv056-B68]). Our findings reveal that the *CYP2D7* gene has been duplicated from *CYP2D6* in a stem lineage of humans and great apes, and the origin of *CYP2D6* and *CYP2D8P* genes in the human genome can be traced back to a stem lineage of the New World monkeys and Catarrhini at the latest. Two functional CYP2D isoforms have been observed in macaques and marmosets, although the copy number of the *CYP2D* genes is different among individuals in the case of macaques ([@evv056-B17]; [@evv056-B59], [@evv056-B61]; [@evv056-B3]). Furthermore, phylogenetic analyses for *CYP2D* genes suggest that the origin of the *CYP2D* subfamily can be traced back to before the divergence between amniotes and amphibians ([@evv056-B68]).

Substrate recognition sites (SRSs) are important for the catalysis of target substrates, and SRSs in the CYP2 family have been determined based on their homology with bacterial CYPs ([@evv056-B11]). The 3D structure of the human CYP2D6 molecule revealed several functional important sites ([@evv056-B63]; [@evv056-B31]; [@evv056-B14]; [@evv056-B44]; [@evv056-B62]). [@evv056-B44] obtained the crystal structure of CYP2D6 with 3.0-Å resolution and revealed that the basic structure of the CYP2D6 is similar to other CYP members. [@evv056-B62] predicted the sites of the reaction center for known CYP2D6 substrates, based on a model of ligand-bound CYP2C5 complexes as a template. [@evv056-B63] and [@evv056-B14] have reported that most substrates of CYP2D6 have a basic nitrogen at a distance of about 5--7 Å (or 10 Å) from the site of oxidation and can interact with Asp-301or Glu-216 ([@evv056-B14]).

The human CYP2D6 enzyme has been studied across various disciplines due to its clinical importance, including pharmacokinetics, pharmacogenetics, structural biology, and clinical medicine. Therefore, *CYP2D6* genetic variation in human populations has been also investigated extensively ([@evv056-B66]; [@evv056-B1]; [@evv056-B30]; [@evv056-B43]; [@evv056-B51]; [@evv056-B7]; [@evv056-B2]). More than 100 human *CYP2D6* alleles, including intron variations, in samples from around the world are described in the Human Cytochrome P450 Allele Nomenclature Database (<http://www.cypalleles.ki.se/cyp2d6.htm>). Additionally, unequal crossover events often cause copy number variation (CNV) of the gene ([@evv056-B16]; [@evv056-B41]; [@evv056-B52]; [@evv056-B28]; [@evv056-B8]). CNV and deleterious mutations of functional *CYP2D6* genes are categorized into four phenotypes based on their ability (rate) to metabolize drugs: A poor (PM), intermediate, efficient (EM), or ultrarapid metabolizer (UM) ([@evv056-B69]). The PMs do not have any functional *CYP2D6*, and thus lack the ability to metabolize drugs. EMs correspond to a wild-type copy of *CYP2D6* with normal function. On the other hand, UMs can have up to 13 copies of *CYP2D6* gene and can rapidly metabolize medicines and thus are unaffected by drugs. The frequency of PMs is relatively higher in Europe than in other areas, whereas UMs are mainly found in North Africa ([@evv056-B51]).

Gene conversion among three *CYP2D* genes has occurred in human populations, and this probably also affects the genetic variation in drug metabolism ([@evv056-B15]; [@evv056-B16]). In human evolution, as people have only recently started to use drugs, drugs cannot be an evolutionary force for CYP2D evolution. Instead, the CYP2D enzyme must have been essential for the detoxification of foods containing plant toxins. Our previous study suggested that lineage-specific *CYP2D* gene expansion in vertebrates can reflect the requirement in an environment ([@evv056-B68]). This suggests that birth-and-death processes in *CYP2D* subfamily are associated with differences of feeding strategies among organisms. Nevertheless, there is little knowledge about the evolutionary pattern or mode of the *CYP2D* subfamily in primates. We here examine molecular evolution of the subfamily by comparing 14 *CYP2D* sequences from humans to New World monkey genomes.

Materials and Methods
=====================

Collection of Nucleotide Sequence Data of *CYP2D* Genes
-------------------------------------------------------

We previously identified the gene organization of the human, chimpanzee, Sumatran orangutan, rhesus monkey, and white-tufted-ear marmoset *CYP2D* genes, based on nucleotide sequence data in the genome database and sequences determined by direct sequencing ([@evv056-B68]). In addition, the *CYP2D6* sequence of the pygmy chimpanzee (Koch WH et al., unpublished data; GenBank accession number, DQ282163) was newly obtained from GenBank. They are human and orangutan *CYP2D6*, *CYP2D7P*, and *CYP2D8P*, pygmy chimpanzee (*Pan paniscus*) *CYP2D6*, common chimpanzee *CYP2D6*, *CYP2D7*, and *CYP2D8P*; and rhesus monkey and marmoset *CYP2D6* and *CYP2D8*. Sequences of the common chimpanzee (from now on we will refer to the common chimpanzee as the chimpanzee.) *CYP2D6* and *CYP2D7* genes were used according to the annotation of our previous study ([@evv056-B68]). In addition, three *CYP2D* homologs from each of the cynomolgus monkey (*Macaca fascicularis*) and marmoset were retrieved from the NCBI (National Center for Biotechnology Information) database (<http://www.ncbi.nlm.nih.gov/>).

As mentioned above, in humans there are more than 100 *CYP2D6* alleles that are categorized into four phenotypes. Thus, the elucidation of *CYP2D* molecular evolution is complicated by the presence of multiple C*YP2D6* alleles in a species. Here, we use the *CYP2D6\*1* allele as the representative *CYP2D6* allele because this allele has the highest allele frequency in human populations ([@evv056-B51]). For putative pseudogenes, the character "*P*" was added after their gene names. Sequence data used in this study and analyses for each of the sequences (see below) are summarized in [supplementary table S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online.

Alignment of *CYP2D* Sequences and Test for Gene Conversion between Paralogous Genes
------------------------------------------------------------------------------------

The alignment of nucleotide sequence data and translation into amino acids were performed using MEGA v5.10 ([@evv056-B56]). The alignment was manually modified, and positions of deletions or insertions (indels) were determined. In the analysis, the pseudogene sequences were also translated according to the frame of *CYP2D6*, although they did not encode proteins, and transmembrane domains were predicted using SOSUI ([@evv056-B18]).

The statistical test for detecting gene conversion was performed using the Two-Sample Runs Test ([@evv056-B55]) and GENECONV program version 1.81 ([@evv056-B48]) which was run with default settings. We applied the Runs Test to *CYP2D6* and *CYP2D7*(*P*) genomic sequences of only human and chimpanzee origin because we were specifically focusing on the human *CYP2D6*. Indels were also treated as informative sites and were used because they were important for detecting gene conversion. The global test for recombination or gene conversion events was used with 10,000 permutations of the sequence alignment to assess the significance. Allelic pairs with Sim-*P* value \< 0.05 were excluded from further analyses.

Phylogenetic Analyses for *CYP2D* Sequences
-------------------------------------------

The neighbor-joining (NJ) trees ([@evv056-B45]) for nucleotide sequences of intron 2 fragment in *CYP2D* genomic regions and amino acid sequences of the entire coding sequences (CDSs) were reconstructed based on the Kimura two-parameter ([@evv056-B24]) and *p*-distance models ([@evv056-B32], respectively. The NJ tree was also constructed based on synonymous substitutions in the *CYP2D* CDSs. Bootstrap analyses for their NJ trees were performed using 1,000 replications. The maximum likelihood (ML) and maximum parsimony (MP) trees were implemented in the PHYLIP 3.69 package ([@evv056-B4]), and constructed on the basis of amino acid sequences at the SRSs. Bootstrap analyses were of 100 and 1,000 replicates for the ML and MP trees, respectively. For the ML tree, global rearrangement was allowed, and the input order of OTU was randomized with three jumbles during randomization. For the MP tree, the jumble option was set ten times. The ML and MP trees were visualized using the TreeView program version 1.6.6 ([@evv056-B39]). All positions containing any indels and missing data were eliminated from the data set (complete deletion option).

Measure of Genetic Distance among *CYP2D* Sequences and Estimation of Natural Selection
---------------------------------------------------------------------------------------

The genetic distances of silent substitutions, which include both synonymous substitutions in the CDSs and changes in noncoding positions, were calculated by DnaSP 5.10.01 software ([@evv056-B27]). A sliding window analysis for the genetic distances of silent substitutions was also implemented in the DnaSP. The number of nonsynonymous substitutions per nonsynonymous site (*d*~N~) and synonymous substitutions per synonymous site (*d*~S~) was estimated with MEGA v5.10, using the distance of the modified Nei--Gojobori ([@evv056-B70]) with the Jukes--Cantor correction ([@evv056-B22]) for multiple substitutions. Standard errors were calculated using 1,000 bootstrapping replicates. Ratios of *d*~N~/*d*~S~ for nine functional *CYP2D6*/*7*/*8* and six *CYP2D6* CDSs were separately calculated at the SRSs and non-SRSs as well as over the entire coding region. In addition, we estimated *ω* ratios (=*d*~N~/*d*~S~) for 14 *CYP2D* CDSs including pseudogenes with the ML method by using CODEML in the PAML program version 4.8 ([@evv056-B67]). Several models that estimate values of *ω* under different scenarios of selective pressure (M0, M1a, M2a, M7, and M8) were considered in this program. A Bayesian approach (Bayes empirical Bayes) in CODEML was used to predict positively selected codons. All indels and codons including nonsense and frameshift mutations were eliminated from the data set for the estimates of *ω* ratios.

Amino Acid Sequences Variation for *CYP2D* Sequences in Primates
----------------------------------------------------------------

Amino acid variability among the 14 *CYP2D* CDSs was calculated using a Wu--Kabat plot ([@evv056-B65]). The Wu--Kabat plot estimates the variability for each amino acid position, which is measured by the number of amino acids at a site divided by the maximum frequency of amino acid at the sites. [@evv056-B65] originally evaluated the variability based on the sequence data for a single species, but here we used the sequences of orthologous genes from six different species, a method we refer to as "the modified Wu--Kabat plot." In this approach, if only a single amino acid appears at a site, the variability is the minimum value of 1, whereas if six different species have six different amino acid at a site, the value is 6/(1/6), or 36, at a maximum.

Estimation of Nonfunctionalization Time of *CYP2D8* genes
---------------------------------------------------------

To estimate nonfunctionalization times (*T*~P~) of *CYP2D8P* genes in humans and orangutans, we calculated relative times of *T*~P~ to species divergence time between the Hominidae and Old World monkeys (*T*~S~). The relative times (*T*~P~/*T*~S~) were obtained from the number of nonsynonymous and synonymous substitutions between a functional gene and pseudogene according to the equation *T*~P~/*T*~S~ = 2 (*d*~N~/*d*~S~ − *f*)/(1 − *f*), by modifying the method of [@evv056-B47]. The parameter *f*, which is the neutral fraction of substitutions, is determined by *f* = *d*~N~*~f~*/*d*~S~*~f~*, where *d*~N~*~f~* and *d*~S~*~f~* are nonsynonymous and synonymous divergence for the functional gene, respectively. We set the parameter *T*~S~ to 35 Ma ([@evv056-B46]). The standard errors of *T*~P~/*T*~S~ were acquired by bootstrapping codons of *CYP2D8P* 10,000 times under a given *f*. In simulations, *T*~P~/*T*~S~ sometimes became negative, attributed to cases where *d*~N~/*d*~S~ \< *f*, due to insufficient time passed for accumulation of nonsynonymous substitutions since the loss of CYP2D8 function, suggesting that it is equivalent to the case of *T*~P~/*T*~S~ = 0.

Results
=======

Phylogenetic Relationships among *CYP2D* Genes in Primates
----------------------------------------------------------

The NJ tree based on synonymous substitutions among 20 *CYP2D* CDSs of seven primates ([fig. 1](#evv056-F1){ref-type="fig"}) showed that orthologous genes did not form a single clade. In the hominid, *CYP2D6* and *CYP2D7* were intermingled together, but *CYP2D8* did not cluster with them. In macaques, rhesus and cynomolgus monkey sequences grouped in a macaque-specific cluster. In marmosets, *CYP2D6* and *CYP2D8* clustered distinctly away from other primates. From this phylogeny, gene diversification was presumed to have occurred at least five times (diamonds 1--5 in [fig. 1](#evv056-F1){ref-type="fig"}). Alternatively, the phylogeny shows that in orangutans, macaques, and marmosets, the conversion between *CYP2D6* and *CYP2D8* occurred in each species (diamonds 2, 4, and 5 in [fig. 1](#evv056-F1){ref-type="fig"}). As the history of *CYP2D6* and *CYP2D7*(*P*) in humans and chimpanzees is not that simple, further phylogenetic analyses were performed to identify the time and location of ectopic gene exchanges. F[ig]{.smallcaps}. 1.---NJ tree of the *CYP2D* genes of primates, based on synonymous substitutions of the entire coding region. The modified Nei--Gojobori method was used as a distance measure with Jukes--Cantor correction. The internal node number represents bootstrap values (\>50%). The diamond represents a gene divergence. The *CYP2D* sequences indicated in bold were obtained from the whole-genome sequence data, and nucleotide sequences of some fragments were determined in our previous study ([@evv056-B68]). The mouse *Cyp2d22* was used as an outgroup sequence. Hosa, human; papa, pygmy chimpanzee; patr, chimpanzee; poab, orangutan; mamu, rhesus monkey; mafa, cynomolgus monkey; caja, white-tufted-ear marmoset; mumu, house mouse.

Gene Conversion between *CYP2D* Genes in Humans and Chimpanzees
---------------------------------------------------------------

For simplicity, *CYP2D6* and *CYP2D7*(*P*) genes in humans and chimpanzees were designated as H6, H7, C6, and C7, respectively. Informative sites of the four sequences were classified into three categories, supporting each of the three topologies. They were ((H6, C6), (H7, C7)), ((H6, H7), (C6, C7)), and ((H6, C7), (C6, H7)) ([fig. 2](#evv056-F2){ref-type="fig"}*A*) and were named α, β, and γ, respectively. As *CYP2D6* and *CYP2D7*(*P*) duplication occurred before the divergence of humans and great apes, the topology α represents an original phylogenetic relationship. On the other hand, the topology β suggests gene conversion within each species, whereas the topology γ might be caused by recurrent substitutions. In fact, a site showing the topology γ was found only once (at the 2213 site) in the 6,924 bp compared, whereas α and β sites showed a block distribution (α1, α2, and β1--β3) ([fig. 2](#evv056-F2){ref-type="fig"}*B* and [supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). F[ig]{.smallcaps}. 2.---(*A*) The possible topologies at parsimony informative sites. In analysis, α topology was expected when a gene duplication event occurred before speciation, whereas β topology was expected when gene conversion or recombination occurred after its duplication. H6, human *CYP2D6* gene; H7, human *CYP2D7P*; C6, chimpanzee *CYP2D6*; C7, chimpanzee *CYP2D7*. (*B*) The alignment of nucleotide sequences based on parsimony informative sites in the *CYP2D6* and *CYP2D7*(*P*) of the human and chimpanzee. The white column indicates α topology. The filled black column indicates β topology. The filled gray column indicates γ topology.

We examined interlocus gene conversion (or recombination) using both Takahata's Two-Sample Runs Test and the GENECONV program. The Runs Test exhibited significant runs of both α and β informative sites ([table 1](#evv056-T1){ref-type="table"}) with *P* values of \<0.001. The analysis by GENECONV was performed using all the *CYP2D* genes of five primates, and it suggested significant gene conversion events in three β regions ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). Table 1Two-Sample Runs Test for Detection of Gene ConversionSister Group StatusAB*PZk*[^a^](#evv056-TF2){ref-type="table-fn"}(β, γ), α26201≈6.9 × 10^−25^105≈7.0 × 10^−26^94≈2.6 × 10^−27^84≈1.9 × 10^−28^73≈5.1 × 10^−30^63≈2.4 × 10^−31^52≈4.2 × 10^−33^42≈9.5 × 10^−35^31≈8.5 × 10^−37^21≪0.001≤10(α, γ), β20225≈5.9 × 10^−25^105≈6.3 × 10^−26^94≈2.3 × 10^−27^84≈1.7 × 10^−28^73≈4.7 × 10^−30^63≈2.3 × 10^−31^52≈4.1 × 10^−33^42≈9.5 × 10^−35^31≈8.5 × 10^−37^21≪0.001≤10[^2][^3]

To determine the timing of the conversion, we constructed a synonymous tree for each of the three β regions of H6, H7, C6, and C7, with orangutan *CYP2D6* and *CYP2D7P* (O6 and O7) as outgroups ([fig. 3](#evv056-F3){ref-type="fig"}). In the trees for the three β regions, orthologous genes did not form a single cluster. For the β1 region, the distance between the orthologs, H6 and C6, was *d*~H6C6~ = 0.013 ± 0.004 and comparable to the genome average (1.23%; [@evv056-B6]). For the paralogous genes, *d*~C6C7~ (0.006 ± 0.003) was smaller than the genomic average. Both C6 and C7 were closer to H6 (0.014 ± 0.004) than to H7 (0.029 ± 0.006), suggesting that it is likely that C6 converts C7. These observations indicate that gene conversion between *CYP2D6* and *CYP2D7*(*P*) occurred at least once in the β1 region in an ancestral population of chimpanzees and humans. In the β2 and β3 regions, on the other hand, independent gene conversion seemed to have occurred in humans and chimpanzees, respectively. In addition, the average genetic divergences between H6/C6 and H7/C7 in the β2 and β3 regions were 0.031 ± 0.007 and 0.029 ± 0.007, respectively. The divergence also reflected the gene conversion between *CYP2D6* and *CYP2D7*(*P*) in an ancestor population of humans and chimpanzees. F[ig]{.smallcaps}. 3.---NJ trees based on the genetic distances of three β regions in *CYP2D6* and *CYP2D7*(*P*) genes of the human, chimpanzee, and orangutan. The genetic distances (three decimal places) were based on silent substitutions, which include synonymous substitutions in coding regions and changes in noncoding regions. H6, human *CYP2D6* gene; H7, human *CYP2D7P*; C6, chimpanzee *CYP2D6*; C7, chimpanzee *CYP2D7*; O6, orangutan *CYP2D6*; O7, orangutan *CYP2D7P*.

Large Genetic Distances in the *CYP2D* Region among Primates
------------------------------------------------------------

We examined genetic divergence in the fragment of intron 2, which appeared to be scarcely affected by gene conversion across the *CYP2D* sequences of four Catarrhini species examined ([supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). The recombination signal was not detected in intron 2 through both Runs test and GENECONV, but genetic distances (*d~\_~*~intron2~) among sequences in the region were still large. For example, *d~\_~*~intron2~ between the human and orangutan *CYP2D6* was 0.08 ± 0.020 ([supplementary table S3*A*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). A sliding window analysis helped elucidate the large genetic distances across the *CYP2D* genomic region ([supplementary fig. S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). To examine whether the genetic divergence was enhanced uniquely in the *CYP2D* region, we calculated the *d*~S~ of the *TCF20* (transcription factor 20) gene that was located adjacent to the *CYP2D8*(*P*) gene. The genetic distances among primate *TCF20* sequences were much lower than *d~\_~*~intron2~ of *CYP2D* (*P* \< 0.001). The value of *d*~S~ between human and orangutan *TCF20* sequences was 0.03 ± 0.002 ([supplementary table S3*B*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online), in good agreement with the genome average (about 3%, [@evv056-B54]; [@evv056-B46]; [@evv056-B42]). This result suggests that the large divergence is specific to the *CYP2D* nonconverted region.

As methylation of CpG sites often results in the large divergence between sequences, we compared GC content and the proportion of CpG sites in the *CYP2D* with those in *TCF20* CDSs. The GC contents of *CYP2D* CDSs and partial intron 2 sequences ranged from 63% to 69%, whereas those of the *TCF20* gene were approximately 52%. The average proportion of CpG sites in the entire *CYP2D* gene was much higher than that in the *TCF20* (*P* \< 0.001; *CYP2D*, 6.4%; *TCF20*, 1.8%). In fact, when CpG methylation-related sites (CG, TG, and CA) were removed from *CYP2D* CDSs, their genetic distances became lower, for example, *d*~S~ = 0.017 ± 0.012 between H6 and C6 intron 2 sequences ([supplementary table S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). These results suggest that genetic distances in the *CYP2D* region have been uniquely enhanced by the high mutation rate at the CpG sites.

Amino Acid Sequences Variation for *CYP2D* Subfamily in Primates
----------------------------------------------------------------

The putative amino acid sequences of the *CYP2D* genes including pseudogenes were aligned. The aligned region is approximately 500 residues long (see [supplementary fig. S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). The amino acid sequences within some regions under the functional and structural constraints, such as heme-binding regions, were relatively conserved among the 14 *CYP2D* genes from the five primates. On the other hand, the sequence similarities of the transmembrane region were rather low.

The amino acid sequences at SRSs between *CYP2D7P* and *CYP2D8P* genes in Hominidae appeared to be more similar to those between *CYP2D6* and *CYP2D7P*. In contrast, at non-SRSs, amino acid sequences of *CYP2D6* and *CYP2D7P* were more similar to each other than those of *CYP2D7P* and *CYP2D8P* ([supplementary fig. S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). In the rhesus monkey and marmoset, amino acid sequences between *CYP2D6* and *CYP2D8* genes were more similar at non-SRSs than at SRSs. To confirm this observation, NJ trees of SRSs and non-SRSs for amino acid sequences and that of intron regions for nucleotide sequences were compared ([fig. 4](#evv056-F4){ref-type="fig"}). In the SRS tree, all the *CYP2D6* genes from primates were monophyletic from the *CYP2D7*(*P*) and *CYP2D8*(*P*) ([fig. 4](#evv056-F4){ref-type="fig"}*A*). The MP and ML trees also supported the same topology even though an outgroup sequence was changed ([supplementary fig. S5](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). The NJ trees of non-SRSs and intron regions showed that paralogous genes of each species formed an intermingled cluster for Hominidae ([fig. 4](#evv056-F4){ref-type="fig"}*B* and *C*). F[ig]{.smallcaps}. 4.---Three phylogenetic trees of primate *CYP2D* genes. (*A*) NJ tree based on amino acid sequences at SRSs. (*B*) NJ tree based on amino acid sequences at non-SRSs. (*C*) NJ tree based on nucleotide sequences in intron regions. A *p*-distance was used as a distance measure for amino acid sequences (*A* and *B*). A genetic distance of nucleotide sequences was calculated by using the Kimura two-parameter model (*C*). Diamond represents a gene divergence. Only bootstrap values over 50% are shown in the NJ tree. The mouse *Cyp2d22* was used as an outgroup sequence. Hosa, human; papa, pygmy chimpanzee; patr, chimpanzee; poab, orangutan; mamu, rhesus monkey; caja; white-tufted-ear marmoset; mumu, house mouse.

The variability within the CYP2D6 amino acid sequences was evaluated using a modified Wu--Kabat plot (See Materials and Methods) ([fig. 5](#evv056-F5){ref-type="fig"}). The level of variability was not significantly different between SRSs and non-SRSs. High heterogeneities of amino acid variability were observed around αB and αJ' helix tail ends and the β2-2 sheet, suggesting that a functional constraint was not so strong in these regions. F[ig]{.smallcaps}. 5.---The variability level at amino acid residues among the *CYP2D6* genes in six primates by modified Wu--Kabat plot. Gray boxes indicate the SRSs identified by [@evv056-B11]. The ordinate axis represents the variability of amino acid residues. The abscissa axis represents the position of the human CYP2D6 molecule.

Estimation of Nonfunctionalization Time of CYP2D8 Enzymes in Hominidae
----------------------------------------------------------------------

A putative nonsense mutation in the *CYP2D8P* gene (site 344 between SRS-4 and SRS-5) was shared between human and chimpanzee lineages ([fig. 6](#evv056-F6){ref-type="fig"} and [supplementary fig. S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online), but it was not shared with orangutans. Additional six independent nonsense and frameshift mutations were found in each of the human, chimpanzee, and orangutan *CYP2D8P* sequences. Based on these observations, pseudogenization occurred independently in a human/chimpanzee ancestor and in an orangutan lineage. No frameshift and nonsense mutations, however, were observed in the rhesus monkey or marmoset *CYP2D8* sequences, suggesting that they are functional. The single independent frameshift mutation of *CYP2D7P* was detected in human and orangutan, but not in the chimpanzee sequence. F[ig]{.smallcaps}. 6.---The chronological order of evolutionary events in the primate *CYP2D* gene cluster, based on the results of this study. The number in a box represents the CYP2D isoforms. A cross mark signifies a loss of function (pseudogene). The number of the site on a box represents a putative deleterious mutation site. A filled arrow and stop mark represent frameshift and nonsense mutations, respectively. The number of the site on the bottom represents the total number of their mutations.

To confirm the relaxation of functional constraint in the *CYP2D8P* pseudogenes, we estimated *ω* ratios under different selective scenarios for the specific lineages by the ML methods, based on the expected topology of *CYP2D8*(*P*) gene tree, (marmoset, (rhesus monkey, (orangutan, (human, chimpanzee)))). The analysis was performed in the similar manner of [@evv056-B71]. The average *ω* value across all branches was 0.34 ([table 2](#evv056-T2){ref-type="table"}A), and the *ω* values on branches of human/chimpanzee/orangutan (*ω* = 1.00, [table 2](#evv056-T2){ref-type="table"}B) *CYP2D8P* genes were higher than those across other branches (*ω* = 0.02, [table 2](#evv056-T2){ref-type="table"}B and C). Table 2Estimates of *ω* Ratios for the Five Primate *CYP2D8*(*P*) Genes under Various ModelsModelnp*ω*LikelihoodModel Comparison*P* ValueAAll branches same *ω*100.34−3,220BHominidae branches *ω*~2~, other branches *ω*~1~13*ω*~1~ = 0.02, *ω*~2~ = 1.00−3,205B versus A3.8 × 10^−8^CHominidae branches *ω*~2~ = 1, other branches *ω*~1~12*ω*~1~ = 0.02, *ω*~2~ = 1.00−3,205C versus B1.0[^4]

It is interesting to know when the human and orangutan *CYP2D8P* genes have lost their function. The relative time (*T*~P~/*T*~S~) of pseudogenization of the gene was calculated using the method described in Materials and Methods (and see [supplementary fig. S6](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). We did not consider gene conversion in *CYP2D8P* from the *CYP2D6* and *CYP2D7*(*P*) genes, because *CYP2D8P* genes in Hominidae consistently formed clusters distinct from the other *CYP2D* genes in α and β regions ([supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). The relative times (*T*~P~/*T*~S~) were 0.50 and 0.16 in human and orangutan *CYP2D8P*s, respectively. Bootstrap analyses showed that mean and standard errors of *T*~P~/*T*~S~ values were 0.54 ± 0.29 and 0.21 ± 0.20 in human and orangutan genes, respectively. The calibration time corresponding to *T*~S~ was set to be the divergence time of 35 Ma between Hominidae and Old World monkeys ([@evv056-B46]). The pseudogenization times of the human and orangutan *CYP2D8P*s were estimated to be about 17.5 Ma (19 ± 10 Ma) and 5.6 Ma (7.4 ± 7 Ma), respectively. Although both estimates have large standard errors, the orangutan CYP2D8 enzyme has lost its function more recently than its counterpart in humans and chimpanzees.

Selection Pressure Operating on *CYP2D* Genes
---------------------------------------------

We calculated the mean *d*~N~ and *d*~S~ values for about 1,500-bp CDSs of functional *CYP2D6*/*D7*/*D8* genes for six primates ([table 3](#evv056-T3){ref-type="table"}). We then examined the ratio of *d*~N~/*d*~S~ in SRSs and non-SRSs separately. In the SRSs, the ratios were 0.79 among the three *CYP2D* genes and 0.48 among only *CYP2D6* genes, whereas those in non-SRSs were 0.32 and 0.24, respectively. The mean *d*~N~ value of SRSs among the three *CYP2D* genes was the highest (0.10 ± 0.017), and that of non-SRSs among *CYP2D6* genes was the lowest (0.03 ± 0.004). A chi-square test showed no statistically significant differences in *d*~N~ and *d*~S~ values between SRSs and non-SRSs ([supplementary table S5](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). However, *d*~N~ values at SRSs among functional *CYP2D* genes were significantly higher than those at non-SRSs (*P* = 5.8 × 10^−10^ by Wilcoxon signed-rank test), although the length of SRSs was short. Table 3Mean *d*~S~ and *d*~N~ Distances among the Functional *CYP2D6*/*D7*/*D8* Genes and among *CYP2D6* GenesNo. of OTUSRSsNon-SRSsEntire Coding Region$\overline{d_{\text{N}}}$$\overline{d_{\text{N}}/d_{\text{S}}}$$\overline{d_{\text{N}}}$$\overline{d_{\text{N}}/d_{\text{S}}}$$\overline{d_{\text{N}}}$$\overline{d_{\text{S}}}$$\overline{d_{\text{N}}/d_{\text{S}}}$Primate functional *CYP2D6/D7/D8* genes[^a^](#evv056-TF5){ref-type="table-fn"}90.10 ± 0.0170.79[\*](#evv056-TF6){ref-type="table-fn"}0.04 ± 0.0040.32[\*](#evv056-TF6){ref-type="table-fn"}0.05 ± 0.0050.12 ± 0.0100.39[\*](#evv056-TF6){ref-type="table-fn"}Primate *CYP2D6* genes60.05 ± 0.0120.48[\*](#evv056-TF6){ref-type="table-fn"}0.03 ± 0.0040.24[\*](#evv056-TF6){ref-type="table-fn"}0.03 ± 0.0040.11 ± 0.0100.28[\*](#evv056-TF6){ref-type="table-fn"}[^5][^6][^7]

By using the PAML program with different selective scenarios (models M0--M8), we estimated values of *ω* for functional *CYP2D* genes in five primates examined ([supplementary table S6](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). In the program, proportions *P*~0~ of sites with *ω* \< 1 (0 \< *ω* \< 1) were more than 75% whereas proportions *P*~2~ of site with *ω* \> 1 were less than 2%.

Discussion
==========

Gene Conversion in the *CYP2D* Cluster in Primates, but Not at the SRSs
-----------------------------------------------------------------------

Although some previous studies have reported that gene conversion affects evolution of *CYP2D* genes in humans ([@evv056-B25]; [@evv056-B10]; [@evv056-B29]), the phylogenetic tree based on amino acids at SRSs in this study indicates little effect of gene conversion between SRS sequences of *CYP2D6* and *CYP2D8*. The SRSs identified by [@evv056-B11] were used in the present analysis, but [@evv056-B13] have also proposed six SRSs. We reconstructed the NJ tree by using amino acids of the recognition sites identified by [@evv056-B13], and confirmed the topological differences between SRSs and non-SRSs (data not shown). Although the definition of SRSs was slightly different between [@evv056-B11] and [@evv056-B13], it is clear that the pattern of nucleotide substitution accumulation is different between the SRSs and non-SRSs based on both definitions.

In the comparison of amino acid sequences among *CYP2D* genes of five primates examined, the sequences of *CYP2D8* in the rhesus monkey and marmoset showed more similarities with those of human *CYP2D6* (H6) and *CYP2D7P* (H7) than the human *CYP2D8P* (H8), for example, 92% between H6 and rhesus monkey *CYP2D8* (R8), 91% between H7 and R8, and 89% between H8 and R8. However, *CYP2D8*(*P*) genes in all the five primates share two *Alu* elements, *AluSX* and *AluSg4*, in intron 1, whereas there is no *Alu* element in intron 1 of all *CYP2D6* and *CYP2D7P* genes ([@evv056-B68]). In addition, the phylogenetic tree of intron 2 fragment, which is scarcely affected by gene conversion, shows that *CYP2D8*(*P*) sequences form a distinct clade from *CYP2D6* and *CYP2D7*(*P*) sequences. Therefore, the *CYP2D7* gene is likely to have been duplicated from the *CYP2D6* after the divergence of hominid species and Old World monkeys at the latest.

Difference in Metabolic Activity Level of CYP2D Enzymes among Primates
----------------------------------------------------------------------

Our findings suggest that SRSs in CYP2D6 and CYP2D8 are scarcely affected by gene conversion to retain substrate specificity for each of their isoforms. CYP2D6 and CYP2D8 in the cynomolgus monkey metabolize the same compounds as humans, namely bufuralol and dextromethorphan, although their drug-metabolizing activity levels are different from those in humans ([@evv056-B61]). In addition, the CYP2D enzyme activity in macaques is more efficient than that in humans. In the marmoset, CYP2D19, a putative CYP2D6 ortholog, exhibits no activity for debrisoquine 4-hydroxylase but has high activity for debrisoquine 5-, 6-, 7-, and 8-hydroxylase, whereas CYP2D30, a putative CYP2D8 ortholog, exhibits high activity for the former and low activity for the latter ([@evv056-B3]). These results suggest that the functional difference between CYP2D6 and CYP2D8 molecules is likely regioselectivity (and may be stereoselectivity) rather than the metabolism of different substrates. Amino acid sequences at SRSs have been likely maintained by purifying selection to retain this regioselectivity even though gene conversion affects the other regions of the gene.

Our results show that macaques and marmosets have at least two functional CYP2D isoforms, whereas Hominidae species appear to have one functional isoform only. [@evv056-B38] measured the relative activity of cynomolgus monkey CYP2D6 and CYP2D8 to human CYP2D6 by using the intrinsic clearance (CL~int~) value, which is commonly used to measure hepatic drug metabolic activity, and revealed that the CL~int~ in monkeys was higher than in the human. This result indicates more effective metabolism in monkeys. Although the actual activity in nonhuman Hominidae is unknown, human CYP2D enzyme had less activity than that of monkeys. It is interesting to know when this decrease in activity occurred.

Enhanced Genetic Distances Caused by the Methylation of CpG Sites
-----------------------------------------------------------------

Genetic distances at intron 2 that appeared unaffected by gene conversion between *CYP2D* orthologous genes in primates were higher than expected, although all informative sites support the ordinary gene-cluster tree. On the other hand, the distances of *TCF20* gene located adjacent to the *CYP2D* region were in good agreement with the expectation of species divergence. In this study, we found that the substitution rate was specifically enhanced in *CYP2D* genes only (but not adjacent genes). This increased the mutation rate in the *CYP2D* genes could be due to CpG site methylation as GC content is higher in these genes relative to the *TCF20* gene. However, such CpG sites have been normally conserved by purifying selection if the gene is important ([@evv056-B60]). The degeneration of CpG sites was possibly caused by a loss of functional constraint in the coding region of a gene. The one possible cause for relaxation of functional constraint on *CYP2D* in hominoids is discussed below.

Pseudogenization of the *CYP2D* Gene in Hominidae
-------------------------------------------------

A nonsense mutation in *CYP2D8P*s was shared in the human and chimpanzee, but two frameshift mutations were independently found in the orangutan *CYP2D8P*, showing that *CYP2D8P*s have independently lost the function in common ancestors of human/chimpanzee and orangutan lineages. The pseudogenization times of human/chimpanzee and orangutan *CYP2D8P*s were estimated to be about 17.5 and 5.6 Ma, respectively. Previous studies reported that the divergence times of humans from orangutans were estimated at about 18 Ma ([@evv056-B46]; [@evv056-B53]). Therefore, our estimation of the pseudogenization time suggests that the *CYP2D8* in human/chimpanzee may have immediately lost its function after the divergence of Hominidae species.

The average *ω* value across all branches in a tree of 14 *CYP2D* genes including both functional genes and pseudogenes estimated by CODEML was significantly lower than unity (*P* \< 1.4 × 10^−7^ by likelihood-ratio test), indicating that purifying selection has generally acted on *CYP2D* genes. In addition, a two-ratio model exhibited that the *ω* value of Hominidae *CYP2D8P* clade was unity. Therefore, the evolutionary mode of the *CYP2D8P* genes may have switched to neutrality after the recent pseudogenization.

In general, animals are thought to perceive bitter or astringent taste as a method to avoid toxins in foods. The Old World monkeys tend to take in more antifeedants, such as condensed tannins and monoterpenes, compared with chimpanzees ([@evv056-B64]). Monkeys with smaller body size are thought to have an advantage for detoxifying plant metabolites, compared with humans and great apes, because the expression rates of microsomal enzyme activity negatively correlates with mammalian body size ([@evv056-B26]).

[@evv056-B58] proposed the idea that primates have developed two different strategies to avoid unpredictable toxic risk. The first is the evolution of a detoxification system (physical adaptation), and the second is an enlargement of daily food diversity to dilute the harmful effect of toxin in foods (behavioral adaptation). Although both strategies are not mutually exclusive, this study supports that monkeys have utilized the former strategy primarily, whereas humans and great apes have utilized the latter. In fact, great apes probably ingest a variety of foods in a day to reduce the toxic effects of plants, although it has been reported that alkaloid-containing plants account for 14% of the diets of the chimpanzees examined ([@evv056-B50]). Hominids are more likely to show insensitivity to the toxic effects than monkeys because of larger body size. It is possible that some *CYP2D* genes are pseudogenized in humans and great apes due to the relaxation of functional constraints in the detoxification system, whereas functional *CYP2D* genes have been retained in macaques and marmosets to efficiently detoxify substrates.

Comparison of Amino Acid Residues at SRSs among CYP2D Molecules in Primates
---------------------------------------------------------------------------

To evaluate differences in *CYP2D* function, we compared amino acid residues at the SRSs of each *CYP2D* gene among primate species. Phe-120 at SRS-1 and Phe-483 at SRS-6 are important for CYP2D6 ligand binding ([@evv056-B13]), and in fact, Phe-120 was conserved in the primates examined, with the exception of Ile-120 in the chimpanzee CYP2D7 (Patr-CYP2D7) ([supplementary fig. S7*A*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). As Phe-120 is responsible for direct π--π interactions with aromatic rings of substrates ([@evv056-B13]), the Patr-CYP2D7 with Ile-120 may lack metabolic activity or have altered regioselectivity in metabolism. The comparison of amino acids at SRSs also shows that Phe-483 is conserved in all primate CYP2D molecules. The side chains of Phe-481 and Phe-483 are involved in interacting with an aromatic ring of a substrate although the importance for direct substrate recognition by these sites is ambiguous ([@evv056-B14]; [@evv056-B44]). Although all CYP2D6 and Patr-CYP2D7 molecules have Phe-481, all CYP2D8 molecules have Val-481 ([supplementary fig. S7*B*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). In addition, Ala-482 is conserved in all CYP2D6s and Patr-CYP2D7, whereas Gly-482 is present in all CYP2D8s ([supplementary fig. S7*C*](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) online). As amino acids at 481 and 482 are unique for CYP2D6s/CYP2D7 and CYP2D8s, there is a possibility that those specificities confer differences in ligand regioselectivity in metabolism.

Purifying Selection Has Acted on SRSs within the *CYP2D* Subfamily
------------------------------------------------------------------

All the values of the *d*~N~/*d*~S~ ratios for functional *CYP2D* genes in primates were significantly less than unity at SRSs (*P* = 9.1 ×10^−4^ by Wilcoxon signed-rank test), non-SRSs (*P* = 2.9 ×10^−11^), and over the entire coding region (*P* = 2.9 × 10^−11^). These results support purifying selection on the SRSs and non-SRSs within the *CYP2D* subfamily among different species. However, positive selection has been reported to act on SRSs in four *CYP2* subfamilies (*CYP2A*, *2B*, *2C*, and *2D*) ([@evv056-B11]), suggesting that different evolutionary forces have acted on SRSs between *CYP2D* orthologs and paralogs. Based on the higher *d*~N~/*d*~S~ ratios and *d*~N~ values at SRSs among functional *CYP2D* genes relative to non-SRSs, we assume that the functional constraint on SRSs of the *CYP2D* subfamily is weaker than that on non-SRSs.

The inference of *ω* ratios under different scenarios of selective pressure in the PAML program showed a remarkably larger proportions of sites with *ω* \< 1 (\>75%) than those with *ω* \> 1 (\<2%). This result supports that amino acid sequences on the SRSs are totally conserved by purifying selection; however, some codons in the region may have been affected by diversifying selection. The Bayesian approach in the PAML analysis identified five positively selected sites (sites 167, 304, 373, 478, and 479; posterior probability, *P* \> 0.95) under models M2a and M8 that allow for positive selection (in this case probably diversifying selection). Of the five codons, four are located within the SRSs, suggesting that the functional constraint of SRSs has been relaxed or diversifying selection has acted on their codons.

Although humans normally have only one functional *CYP2D* gene, mice have nine functional *Cyp2d* genes ([@evv056-B36]), and there are 12 rodent *Cyp2d* genes that show evidence of positive selection ([@evv056-B57]). In contrast, we have found evidence of purifying selection in primate *CYP2D* genes. As a hypothesis, drug-metabolizing enzymes may have evolved by "plant--animal warfare" ([@evv056-B10]; [@evv056-B16]), and the human CYP2D6 enzyme also has a very high affinity for plant toxins such as alkaloids ([@evv056-B5]). [@evv056-B21] has assumed that the difference in selective pressures for dietary detoxification potential resulted in the variance of the number of functional *CYP2D* genes between the human and mouse. The results of our study suggest that each *CYP2D* member in primates has evolved to retain different regioselectivity for a substrate in order to keep this function, and the moderate purifying selection may operate on each *CYP2D* gene, even though gene conversion widely affects the *CYP2D* genomic region.

In this study, we found that gene conversion and purifying selection have affected homogeneities between *CYP2D* paralogous genes in primates. In contrast, amino acids at SRSs have been moderately diversified between their paralogous genes. According to the number of functional *CYP2D* genes, macaques and marmosets appear to metabolize toxins in food more efficiently than Hominidae. Our findings, moreover, suggest that the methylation of CpG sites enhanced the divergence of *CYP2D* genes in the primates examined. In the near future, the development of a genome database for a variety of species will enable the analysis of intraspecies or interspecies genome-wide sequences.

Supplementary Material
======================

[Supplementary tables S1--S6](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) and [figures S1--S7](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evv056/-/DC1) are available at *Genome Biology and Evolution* online (<http://www.gbe.oxfordjournals.org/>).
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[^1]: **Associate editor:** Yoshihito Niimura

[^2]: N[ote]{.smallcaps}.---α, a sister group state, \[(H6, C6),(H7, C7))\]; β, a sister group state, \[(H6, H7),(C6, C7))\]; γ, a sister group state, \[(H6, C7),(H7, C6))\]. H6, human *CYP2D6*; H7, human *CYP2D7P*; C6, chimpanzee *CYP2D6*; C7, chimpanzee *CYP2D7.* A, site defined as one that does not support a certain sister group status; B, site defined as one that supports the specified sister group status; *Z*, continuum of the same sister group status (run).

[^3]: ^a^*Z* = 2 *k* when the number of *Z* is even, and *Z* = 2 *k* + 1, when the number of *Z* is odd.

[^4]: Note.---np, number of parameters.

[^5]: N[ote]{.smallcaps}.---The *d*~S~ and *d*~N~ values are calculated by the modified Nei--Gojobori method with Jukes--Cantor (*R* = 2.25; [@evv056-B70]).

[^6]: ^a^Excluding *CYP2D7P* genes of the human and orangutan and *CYP2D8P* genes of Hominidae.

[^7]: \**P* \< 0.05 (*d*~N~ \> *d*~S~; Wilcoxon signed-rank test).
